0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Medicine and Public Policy |

A Consortium for Purchase of Blood Products Directed by Physicians

LOUIS M. ALEDORT, M.D.; RICHARD A. LIPTON, M.D.; and MARGARET HILGARTNER, M.D.
[+] Article and Author Information

Grant support: in part by the National Heart, Lung, and Blood Institute, Bethesda, MD; Health Services Administration grant MCB-360001-04-01; Health and Human Services Grant HL-30567-02; the Regional Comprehensive Hemophilia Diagnostic and Treatment Center; the Margie Boas Fund; the International Hemophilia Training Center of the World Federation of Hemophilia; and the Polly Annenberg Levee Hematology Center, Department of Medicine, Mt. Sinai School of Medicine of the City University of New York, New York, New York.

▸ Requests for reprints should be addressed to Louis M. Aledort, M.D.; Mt. Sinai Medical Center, Department of Medicine, 1 Gustave L. Levy Place; New York, NY 10029-6574.


New York and New Hyde Park, New York


© 1988 American College of PhysiciansAmerican College of Physicians


Ann Intern Med. 1988;108(5):754-756. doi:10.7326/0003-4819-108-5-754
Text Size: A A A

Clotting-factor therapy is a costly part of comprehensive hemophilia treatment. Physicians treating patients with hemophilia in New York formed a consortium for the purchasing and regional distribution of clotting-factor concentrates. Concentrates are centrally purchased based on a bidding formula aimed at obtaining the lowest price for quality product while guaranteeing all suppliers continued involvement in a large market area. The consortium has successfully maintained, and, in instances, lowered prices each year. Estimated regional savings this year are more than $750 000 for an anticipated purchase of approximately 60 000 000 units of clotting-factors VIII and IX. Central distribution has additionally lowered costs to participating hospitals. The consortium is able to provide patients and third-party payers with some of the lowest prices for clotting-factor concentrates in the United States. A physician-directed regional approach to purchasing costly medical products might be applied to other areas of clinical medicine.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)